Low Dose Naltrexone & Fibromyalgia


The Safety and Efficacy of Low-Dose Naltrexone in the Management of Chronic Pain and Inflammation in Multiple Sclerosis, Fibromyalgia, Crohn's Disease, and Other Chronic Pain Disorders.

 

Low Dose Naltrexone in the Treatment of Fibromyalgia.

 

Low-Dose Naltrexone (LDN)-Review of Therapeutic Utilization.

 

Low-Dose Naltrexone for the Treatment of Fibromyalgia: Investigation of Dose-Response Relationships.

 

The Use and Utility of Low-dose Naltrexone Capsules for Patients with Fibromyalgia.

 

Pharmacology Update: Low-Dose Naltrexone as a Possible Nonopioid Modality for Some Chronic, Nonmalignant Pain Syndromes.

 

Reduced Pro-Inflammatory Cytokines after Eight Weeks of Low-Dose Naltrexone for Fibromyalgia.

 

Low-Dose Naltrexone for Chronic Pain: Update and Systemic Review.

 

Low-dose naltrexone as a treatment for chronic fatigue syndrome.

 

Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels.

 

Clinical utility of the cold pressor test: evaluation of pain patients, treatment of opioid-induced hyperalgesia and fibromyalgia with low dose naltrexone.

 

The Use of Naltrexone in Low Doses Beyond the Approved Indication.

 

The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain.

 

[Low dose naltrexone for treatment of pain].

 

Featured Article: Serum [Met(5)]-enkephalin levels are reduced in multiple sclerosis and restored by low-dose naltrexone.

 

Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study.

 

Use of low-dose naltrexone in the management of chronic pain conditions: A systematic review.

 

Low-dose naltrexone and opioid consumption: a drug utilization cohort study based on data from the Norwegian prescription database.

 

Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis.

 

Intermittent blockade of OGFr and treatment of autoimmune disorders.

 

Is fibromyalgia an endocrine/endorphin deficit disorder? Is low dose naltrexone a new treatment option?

 

Is there a role for opioids in the treatment of fibromyalgia?

 

Fibromyalgia, autism, and opioid addiction as natural and induced disorders of the endogenous opioid hormonal system.

 

A control systems engineering approach for adaptive behavioral interventions: illustration with a fibromyalgia intervention.